InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake. Fund-I made 8 investments during the period 2007-12 and has exited all 8 investments. ILSF-II is partially exited with 12 investments and 8 exits. ILSF-III is fully invested with 13 investments.
View Top Employees from InvAscentWebsite | http://www.invascent.com |
Revenue | $1 million |
Employees | 13 (12 on RocketReach) |
Address | 1174-A Road No. 56, Jubilee Hills, Hyderabad, Telangana 500033, IN |
Phone | (650) 949-2248 |
Industry | Venture Capital and Private Equity Principals, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular InvAscent employee's phone or email?
The InvAscent annual revenue was $1 million in 2024.
Sumit Gupta is the Managing Director of InvAscent.
12 people are employed at InvAscent.
InvAscent is based in Hyderabad, Telangana.
The NAICS codes for InvAscent are [3254, 325, 32541, 32].
The SIC codes for InvAscent are [283, 28].